Sinovac’s COVID-19 vaccine is conditionally registered in South Africa
A vial marked “Sinovac COVID-19 Vaccine” is shown in this illustration taken January 16, 2022. REUTERS / Dado Ruvic / Illustration
Sign up now for FREE unlimited access to Reuters.com
June 25 (Reuters) – China’s Sinovac Biotech (SVA.O) said on Saturday that the South African Health Products Regulatory Authority has granted conditional registration of its coronavirus vaccine CoronaVac to persons aged 18 and over.
Sign up now for FREE unlimited access to Reuters.com
Reporting of Akanksha Khushi in Bengaluru; Editing Sam Holmes
Our standards: Thomson Reuters trust principles.